Keyphrases
Meta-analysis
100%
Systematic Meta-analysis
100%
Chronic Kidney Disease
73%
Prospective Randomized Trial
64%
Adverse Events
64%
Acute Kidney Injury
43%
Hypertension
38%
Kidney Disease
36%
Cardiovascular Outcomes
34%
Deprivation
32%
Poor Outcome
32%
Hygia Chronotherapy Trial
32%
Chronotherapy
32%
Database Research
32%
Usual Care
32%
Expert Opinion
32%
Ischemic Heart Disease
32%
Delphi Method
32%
Allopurinol
32%
Scoping Review
32%
Consensus Definition
32%
Medical Education
32%
Contrast-induced Nephropathy
32%
Intravenous Contrast
32%
Junior Doctors
32%
Hypertension Management
32%
Cardiovascular Risk Reduction
32%
Performance Gap
32%
Devil
32%
Well-being
32%
Overall Health
32%
Pain Prevalence
32%
Adults with Hypertension
32%
Bedtime
32%
Clinical Trials
32%
Antihypertensive Medication
32%
Morning Dosing
32%
Analgesic Use
32%
Mentorship
32%
COVID-19 Vaccination
32%
Contrast Exposure
32%
Safety Study
32%
Confidence Interval
27%
Mentoring Program
24%
Clinical Practice
24%
Reactogenicity
21%
Evening Dosing
19%
Hospitalization
17%
Random-effects Meta-analysis
16%
Renal Disease
16%
Medicine and Dentistry
Systematic Review
100%
Meta-Analysis
100%
Chronic Kidney Disease
67%
Adverse Event
64%
Prevalence
50%
Cardiovascular System
45%
Clinical Trial
39%
Drug Therapy
39%
Antihypertensive Agent
32%
Anodyne
32%
Acute Kidney Injury
32%
Physician
32%
Allopurinol
32%
Contrast-Induced Nephropathy
32%
Wellbeing
32%
COVID-19 Vaccination
32%
Ischemic Heart Disease
32%
Antihypertensive
32%
Reactogenicity
18%
Intention-to-Treat Analysis
14%
Hazard Ratio
14%
Opiate
13%
Nephropathy
12%
Apoplexy
11%
Myocardial Infarction
11%
Kidney Graft
10%
Care Group
10%
Meta-Regression
9%
Creatinine
9%
Health Care
9%
Nonsteroid Antiinflammatory Agent
9%
Premenstrual Syndrome
9%
Renal Replacement Therapy
9%
Attributable Risk
9%
Gout
8%
Kidney Function
7%
Gene Linkage
6%
Patient with Hypertension
6%
National Health Service
6%
Cardiovascular Disease
6%
Antihypertensive Therapy
6%
Subgroup Analysis
5%
Pain (Symptom)
5%
Nephrology
5%
Chronic Pain
5%
Awareness
5%
Abdominal Pain
5%
Neuropathic Pain
5%
Study Heterogeneity
5%
Musculoskeletal Pain
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
72%
Adverse Event
64%
Prevalence
50%
Clinical Trial
36%
Contrast Induced Nephropathy
32%
Kidney Disease
32%
Antihypertensive Agent
32%
Analgesic Agent
32%
Chronotherapy
32%
Antihypertensive
32%
Disease
20%
Acute Kidney Failure
16%
Cardiovascular Risk
16%
Opiate
13%
Premenstrual Syndrome
9%
Iodinated Contrast
9%
Replacement Therapy
9%
Non-Steroidal Anti-Inflammatory Drug
9%
Antihypertensive Therapy
6%
Heart Infarction
6%
Cerebrovascular Accident
6%
Cardiovascular Disease
6%
Abdominal Pain
5%
Neuropathic Pain
5%
Chronic Pain
5%
Musculoskeletal Pain
5%
